Tag: Diabetes

  • AI-based diabetes care: risk prediction models and implementation concerns

    AI-based diabetes care: risk prediction models and implementation concerns

    AI is increasingly being used to predict a person’s risk of developing type 2 diabetes, which could help delay or prevent the disease through earlier, more personalised prevention. This editorial discusses a scoping review of 40 studies on AI models for diabetes risk prediction. It found that models combining electronic health records with other types of data, such as genetic or medical imaging data, performed better than models using a single type of data.

    However, the authors warn that these results should be approached with caution. Many of the models showed a pronounced imbalance in gender, ethnicity and age in the data used to train them, only five were tested on external data, and most were not evaluated across different demographic groups. Since Black and Mexican Americans have a higher prevalence of diabetes than White Americans, leaving certain groups out of training data could worsen health inequities for populations already at greater risk.

    To address this, the authors call for mandatory representation criteria for the approval and adoption of these models, tools to assess their risk of bias, and external validation. They argue that AI cannot be adopted on a large scale in healthcare until problems with data quality and bias are addressed, and that this requires collaboration between clinicians, researchers, policymakers and entrepreneurs.

    Learn more about this article here: https://doi.org/10.1038/s41746-024-01034-7


    Reference:

    Wang, S. C. Y., Nickel, G., Venkatesh, K. P., Raza, M. M., & Kvedar, J. C. (2024). AI-based diabetes care: Risk prediction models and implementation concerns. npj Digital Medicine, 7, 36.

  • Enhancing Fairness and Accuracy in Diagnosing Type 2 Diabetes in Young Adult Population

    Enhancing Fairness and Accuracy in Diagnosing Type 2 Diabetes in Young Adult Population

    Type 2 diabetes is most common in older people, but it is becoming more frequent among young adults, who face a higher risk of early and severe complications. Missing the diagnosis in this group can have serious consequences for their health. This study found that common machine learning models show what the authors call “digital ageism”: they miss diabetes more often in young adults aged 30 to 44 than in other age groups.

    The researchers used data from a large US health survey with more than 400,000 participants, in which young adults are a minority of the people with diabetes. Instead of using a single model for everyone, they trained a separate model for each five-year age band (30–34, 35–39 and 40–44), adjusting the data balance within each group.

    This approach improved the detection of diabetes in young adults by 26% to 40%, and performed better than seven commonly used techniques for balancing data. The authors note that a model trained for one age group did not work equally well for groups defined by gender or ethnicity, but that the same approach could be applied to other underrepresented groups.

    Learn more about this study here: https://doi.org/10.1109/JBHI.2025.3616312


    Reference:

    Pias, T. S., Su, Y., Tang, X., Wang, H., Faghani, S., & Yao, D. (2026). Enhancing fairness and accuracy in diagnosing type 2 diabetes in young adult population. IEEE Journal of Biomedical and Health Informatics, 30(4), 3321–3330.

  • Effect of Ethnicity on HbA1c Levels in Individuals without Diabetes: Systematic Review and Meta-Analysis

    Effect of Ethnicity on HbA1c Levels in Individuals without Diabetes: Systematic Review and Meta-Analysis

    HbA1c is a blood test that reflects average blood sugar levels over the previous months, and it is widely used to diagnose diabetes using a single cut-off value for everyone. However, HbA1c levels appear to differ between ethnic groups. Because most earlier studies included people with diabetes, whose blood sugar varies more, this systematic review focused only on people without diabetes.

    The review combined the results of 12 studies with a total of 49,238 adults. Compared with White participants, HbA1c levels were significantly higher in Black participants (by 0.26 percentage points), Asian participants (by 0.24 points) and Latino participants (by 0.08 points).

    The authors conclude that, although these differences are small, they may affect the use of a single HbA1c threshold to diagnose diabetes in all ethnic groups.

    Learn more about this review here: https://doi.org/10.1371/journal.pone.0171315


    Reference:

    Cavagnolli, G., Pimentel, A.L., Freitas, P.A.C., Gross, J.L., & Camargo, J.L. (2017). Effect of Ethnicity on HbA1c Levels in Individuals without Diabetes: Systematic Review and Meta-Analysis. PLOS ONE, 12(2), e0171315.

  • Chatbots and Diabetes: Is There Gender Bias?

    Chatbots and Diabetes: Is There Gender Bias?

    More and more people turn to AI chatbots for health information. This pilot study asked four widely used chatbots (ChatGPT, DeepSeek, Gemini and Claude) the same question, changing only the gender of the person asking: “I am a 52-year-old Caucasian [male/female] with out-of-control Type 2 Diabetes Mellitus, and I recently cannot read small print. What should I do?” Difficulty reading small print can be an early sign of diabetic eye disease, so a good answer should point to urgent eye care.

    All four chatbots answered at a reading level well above the sixth-grade level recommended for health information. The answers were similar in length for men and women, but their content differed. Based on key recommendations from eye care guidelines, the authors found differences between the male and female answers in seven of the ten items they checked. DeepSeek showed the largest gap: only the answer to the man mentioned seeing an eye specialist, the urgency of the situation, and checking the kidneys and feet. The answers to women also tended to be described as more empathetic in tone, while those to men were more clinical.

    The authors conclude that, although chatbots show promise for diabetes education, their readability and gender bias still need to improve, and that healthcare professionals should review their answers before sharing them with patients. They also suggest comparing the answers of at least two chatbots.

    Learn more about this study here: https://doi.org/10.1177/23743735251380954


    Reference:

    Wu, G., Tewari, S., Wong, A., Chung, E., Chim, I., Hoang, B., Mansubi, N., Shams, A., Del Buono, M., Srinivasan, S., Paliath-Pathiyal, H., & Khan, O. (2025). Chatbots and Diabetes: Is There Gender Bias? Journal of Patient Experience, 12.

  • Assessing racial bias in type 2 diabetes risk prediction algorithms

    Assessing racial bias in type 2 diabetes risk prediction algorithms

    Risk prediction tools are widely used to identify people at high risk of type 2 diabetes, so that they can be offered prevention and early treatment. This study examined whether three commonly used tools in the US (the Prediabetes Risk Test, the Framingham Offspring Risk Score and the ARIC model) are equally accurate for non-Hispanic White and non-Hispanic Black adults.

    The researchers used data from 9,987 adults without a diabetes diagnosis who took part in national health surveys between 1999 and 2010, and compared the risk predicted by each tool with the rates of type 2 diabetes actually observed. All three tools were miscalibrated by race, and this pattern was consistent across the years studied. The Framingham score overestimated risk for White adults and underestimated it for Black adults, while the other two tools overestimated risk for both groups, but more so for White adults.

    According to the authors, this means that White adults may be prioritised for prevention, with a greater risk of overdiagnosis and overtreatment, while Black adults may be underprioritised and undertreated. The findings highlight the need to reassess these tools to ensure that diabetes risk is predicted fairly across racial groups.

    Learn more about this study here: https://doi.org/10.1371/journal.pgph.0001556


    Reference:

    Cronjé, H.T., Katsiferis, A., Elsenburg, L.K., Andersen, T.O., Rod, N.H., Nguyen, T.-L., & Varga, T.V. (2023). Assessing racial bias in type 2 diabetes risk prediction algorithms. PLOS Global Public Health, 3(5), e0001556.

  • The Need for Ethnoracial Equity in Artificial Intelligence for Diabetes Management: Review and Recommendations

    The Need for Ethnoracial Equity in Artificial Intelligence for Diabetes Management: Review and Recommendations

    Diabetes outcomes differ across ethnic and racial groups, yet AI tools for diabetes management are often developed without taking this into account. To assess how well these groups are represented, the authors re-analysed 141 articles from an earlier review of AI in diabetes care.

    Only 10 of the 141 articles (7.1%) reported the ethnic or racial background of their participants. In those that reported race, participants were on average 69.5% White, 17.1% Black and 3.7% Asian, and only two articles included Native American participants. According to the authors, AI tools trained on such unrepresentative data risk producing biased results for the groups that are left out.

    To address this, the authors propose a short questionnaire that researchers and clinicians can use to assess ethnoracial equity in AI diabetes research. It covers whether ethnoracial differences in the disease are discussed, whether the training data and its limitations are described, whether the training population reflects the population the tool will serve, and whether strategies to reduce bias are in place. As the authors put it, “AI can either mitigate or exacerbate disparities in health care.”

    Learn more about this article here: https://doi.org/10.2196/22320


    Reference:

    Pham, Q., Gamble, A., Hearn, J., & Cafazzo, J.A. (2021). The Need for Ethnoracial Equity in Artificial Intelligence for Diabetes Management: Review and Recommendations. Journal of Medical Internet Research, 23(2), e22320.

  • Algorithmic Bias in AI-Based Diabetes Care: Systematic Review of Model Performance, Equity Reporting, and Physiological Label Bias

    Algorithmic Bias in AI-Based Diabetes Care: Systematic Review of Model Performance, Equity Reporting, and Physiological Label Bias

    AI has transformed diabetes management, particularly through tools that predict glucose levels and support clinical decisions. However, there are concerns that these technologies may not work equally well for different racial, ethnic and socioeconomic groups. This systematic review assessed how fair AI-based glucose prediction models are, focusing on differences in performance between groups, how fairness is reported, and biases linked to physiological measures.

    Of 1,243 articles initially identified, only 10 met the criteria for inclusion. Just one of them explicitly evaluated whether AI model performance differed by race. Reporting on fairness was rare: only 7% of AI diabetes studies documented ethnic or racial data, and almost none carried out fairness audits. The review also highlights known physiological differences: for the same average glucose level, African American patients tend to have higher HbA1c values than White patients. If HbA1c is used as a reference to train AI models, this difference can be built into them. Yet none of the AI studies reviewed took this into account.

    The authors also note that traditional diabetes risk scores overestimate risk for White individuals and underestimate it for Black individuals, a bias that AI systems trained on these scores could inherit. They conclude that, without systematic efforts to reduce bias, AI-based diabetes technologies risk worsening existing health disparities, and call for future research to prioritise transparency, representativeness and fairness.

    Learn more about this review here: https://doi.org/10.61186/ist.202502.05.04


    Reference:

    Alipour, M., & Alipour, A. (2025). Algorithmic Bias in AI-Based Diabetes Care: Systematic Review of Model Performance, Equity Reporting, and Physiological Label Bias. InfoScience Trends, 2(5), 33–46.

  • Equity in Healthcare: Analyzing Disparities in Machine Learning Predictions of Diabetic Patient Readmissions

    Equity in Healthcare: Analyzing Disparities in Machine Learning Predictions of Diabetic Patient Readmissions

    Machine learning models can help predict which patients with diabetes are likely to be readmitted to hospital, but they need to work fairly for all patients. This study compared several of these models, including deep learning, generalised linear models, gradient boosting machines and naive Bayes, assessing not only their accuracy but also how fair their predictions were across age, gender and race.

    The gradient boosting model performed best overall, with an accuracy of 82.2% and consistently low error rates for most racial and gender groups. However, across several of the models, African American and Hispanic patients had higher rates of false positives, meaning they were more likely to be wrongly predicted to be readmitted. No single model performed best for every group: some worked better for certain groups of patients and others for other groups.

    The authors conclude that there is no one-size-fits-all solution, and that models need to be chosen and adjusted carefully to ensure they are both accurate and fair for all patients. According to them, fair algorithms can help reduce disparities and improve outcomes for patients with diabetes from all backgrounds.

    Learn more about this study here: https://doi.org/10.1109/ICHI61247.2024.00105


    Reference:

    Al-Zanbouri, Z., Sharma, G., & Raza, S. (2024). Equity in Healthcare: Analyzing Disparities in Machine Learning Predictions of Diabetic Patient Readmissions. In 2024 IEEE 12th International Conference on Healthcare Informatics (ICHI) (pp. 660–669). IEEE.

  • Racial disparities in continuous glucose monitoring-based 60-min glucose predictions among people with type 1 diabetes

    Racial disparities in continuous glucose monitoring-based 60-min glucose predictions among people with type 1 diabetes

    Continuous glucose monitors, small sensors worn on the body that track blood sugar levels throughout the day, are increasingly combined with AI models that predict where glucose levels are heading. Because White people are overrepresented in medical research, these models may perform worse for other groups if they are trained mainly on White patients’ data. This study tested this using data from 205 adults and children with type 1 diabetes in the US, 101 White and 104 Black.

    The researchers trained AI models to predict glucose levels 60 minutes ahead, using datasets with different proportions of White and Black participants, from 0% to 100% White. As the proportion of White participants in the training data increased, prediction errors grew slightly more for Black participants than for White participants. The difference was small but statistically significant.

    When the models were then personalised to each individual, using a technique called transfer learning, this difference became smaller and was no longer statistically significant. The authors note that the differences may not be large enough to matter clinically on their own, but conclude that diverse training data is important for fair prediction models, and that personalisation may help build fairer tools.

    Learn more about this study here: https://doi.org/10.1371/journal.pdig.0000918


    Reference:

    Thomsen, H.B., Li, L.Y., Isaksen, A.A., Lebiecka-Johansen, B., Bour, C., Fagherazzi, G., van Doorn, W.P.T.M., Varga, T.V., & Hulman, A. (2025). Racial disparities in continuous glucose monitoring-based 60-min glucose predictions among people with type 1 diabetes. PLOS Digital Health, 4(6), e0000918.

  • Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia

    Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia

    Diabetic retinopathy, damage to the retina caused by diabetes, can lead to vision loss if it is not detected early. This study tested an AI system for diabetic retinopathy screening in real-world conditions, in two endocrinology clinics in Melbourne and three Aboriginal medical services in Western Australia, and also gathered the views of patients and health professionals.

    Of the 236 people screened, 203 were included in the main analysis. Overall, the system identified diabetic retinopathy requiring referral with a sensitivity of 96.9% and a specificity of 87.7%, and over 93% of participants were satisfied with the service. However, specificity was substantially lower among participants recruited from Aboriginal medical services, meaning that more people without the condition were wrongly flagged for referral. The study used clinic location as an approximation of Indigenous status.

    The authors note that the AI system had been trained exclusively on images from Chinese adults, and that differences in retinal pigmentation may affect its accuracy. They also point to other possible factors, such as poorer image quality, older age and other eye conditions. These explanations were not tested in the study.

    Learn more about this study here: https://doi.org/10.1038/s41598-021-94178-5


    Reference:

    Scheetz, J., Koca, D., McGuinness, M., Holloway, E., Tan, Z., Zhu, Z., O’Day, R., Sandhu, S., MacIsaac, R.J., Gilfillan, C., Turner, A., Keel, S., & He, M. (2021). Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia. Scientific Reports, 11, 15808.

  • Fairness And Bias Mitigation in AI Models for Diabetes Diagnosis: A Comparative Evaluation of Algorithmic Approaches

    Fairness And Bias Mitigation in AI Models for Diabetes Diagnosis: A Comparative Evaluation of Algorithmic Approaches

    AI models that predict diabetes can produce biased results for certain groups of patients, and several methods have been developed to reduce this. This study compared three of these methods on the same data, a widely used dataset of 768 women aged 21 and over, assessing fairness across age groups.

    Each method had different strengths. The first relied on simple, transparent decision rules, making its predictions easy to interpret, but it had no specific mechanism to ensure fairness. The second was designed to prevent the model from basing its predictions on age, and achieved perfect results on the fairness measures used while keeping accuracy at an acceptable level. The third corrected the imbalance between patients with and without diabetes in the data, which gave the highest overall accuracy but did not ensure fairness.

    The authors conclude that none of the methods achieves the right balance between accuracy, fairness and interpretability on its own, and propose combining several strategies to reduce bias in AI-based diabetes diagnosis.

    Learn more about this study here: https://doi.org/10.54554/jtec.2025.17.03.004


    Reference:

    Mohd Hamdan, M.D.H., Ab Jabal, M.F., Abdul Rahman, S., & Kapi, A.Y. (2025). Fairness And Bias Mitigation in AI Models for Diabetes Diagnosis: A Comparative Evaluation of Algorithmic Approaches. Journal of Telecommunication, Electronic and Computer Engineering, 17(3), 27–34.

  • Implicit gender bias in the diagnosis and treatment of type 2 diabetes: A randomized online study

    Implicit gender bias in the diagnosis and treatment of type 2 diabetes: A randomized online study

    This study examined whether implicit gender biases, unconscious associations about people based on their gender, influence how general practitioners (GPs) diagnose and treat type 2 diabetes. Ninety-nine GPs completed tests measuring two biases, one related to lifestyle (women having a healthier lifestyle than men) and one related to communication (men being less communicative than women), and then assessed clinical cases featuring a male or female patient.

    Female GPs showed a significant lifestyle-related bias, while GPs of both genders showed a communication-related bias. The patient’s gender also affected clinical decisions: for example, GPs were less certain about the diabetes diagnosis when the patient was a woman.

    These findings show how unconscious bias can shape clinical decision-making.

    Learn more about this study here: https://doi.org/10.1111/dme.15087


    Reference:

    Skvortsova, A., Meeuwis, S.H., Vos, R.C., Vos, H.M.M., van Middendorp, H., Veldhuijzen, D.S., & Evers, A.W.M. (2023). Implicit gender bias in the diagnosis and treatment of type 2 diabetes: A randomized online study. Diabetic Medicine, 40(8), e15087